Kouri Nikoleta M, Stangou Maria, Lioulios George, Mitsoglou Zoi, Serino Grazia, Chiurlia Samantha, Cox Sharon Natasha, Stropou Persia, Schena Francesco P, Papagianni Aikaterini
Department of Nephrology, School of Medicine, Aristotle University of Thessaloniki, General Hospital "Hippokratio", 54642 Thessaloniki, Greece.
National Institute of Gastroenterology "S. de Bellis", Research Hospital, Castellana Grotte, 70013 Bari, Italy.
J Clin Med. 2021 May 5;10(9):1987. doi: 10.3390/jcm10091987.
BACKGROUND/AIMS: Previous studies showed that two microRNAs, let-7b and miR-148, which regulate the O-glycosylation process of IgA1, may predict diagnosis of primary IgA nephropathy (IgAN). The combined analysis of their serum levels in calculated statistical models may act as serum biomarkers for the diagnosis of primary IgAN. In the present study, we aimed to assess their impact not only on clinical and histological findings at onset but also on renal function after a long-term follow-up.
We enrolled 61 Caucasian patients with biopsy-proven IgAN. Serum levels of miR-148b, let-7b, and galactose-deficient IgA1 (Gd-IgA1) at the time of diagnosis were measured using real-time quantitative PCR and enzyme-linked immunosorbent assay using the monoclonal antibody KM55, respectively. Their values along with calculated Models 1 and 2 were correlated with histologic scoring system (Oxford classification system) and with renal function at diagnosis and after 11.9 ± 6.6 years. Fifty-five healthy volunteers were enrolled as controls.
No significant correlation was found between miRNA and Gd-IgA1 levels and eGFR and proteinuria at diagnosis. A significant negative association was detected between the presence of crescents and serum levels of let-7b ( = 0.002), miR-148b ( = 0.01), and Models 1 and 2 ( = 0.02 and = 0.007, respectively). At the end of follow-up, eGFR correlated with let-7b levels ( = 0.01), Model 1 ( = 0.002), and Model 2 ( = 0.004). Patients with fast progression of the renal damage had significantly increased levels of let-7b ( = 0.01), Model 1 ( = 0.003), and Model 2 ( = 0.005) compared to slow progressors, as did those who reached ESKD ( = 0.002, = 0.001, and = 0.001, respectively). Results were most prominent in those treated with corticosteroids. Finally, cut off levels in Models 1 and 2 could also predict the renal function outcome after long-term follow-up.
Serum levels of let-7b and miR-148b and their combination, may serve as predictors for long-term renal function outcomes, particularly in patients treated with corticosteroids.
背景/目的:先前的研究表明,两种微小RNA,即let-7b和miR-148,可调节IgA1的O-糖基化过程,可能有助于原发性IgA肾病(IgAN)的诊断。在计算统计模型中对它们的血清水平进行综合分析,可作为原发性IgAN诊断的血清生物标志物。在本研究中,我们旨在评估它们不仅对发病时的临床和组织学表现的影响,还对长期随访后的肾功能的影响。
我们纳入了61例经活检证实为IgAN的白种人患者。分别使用实时定量PCR和使用单克隆抗体KM55的酶联免疫吸附测定法,测量诊断时miR-148b、let-7b和半乳糖缺乏型IgA1(Gd-IgA1)的血清水平。它们的值以及计算出的模型1和模型2与组织学评分系统(牛津分类系统)以及诊断时和11.9±6.6年后的肾功能相关。纳入55名健康志愿者作为对照。
诊断时,未发现miRNA和Gd-IgA1水平与估算肾小球滤过率(eGFR)和蛋白尿之间存在显著相关性。在有新月体的患者与let-7b血清水平(P = 0.002)、miR-148b血清水平(P = 0.01)以及模型1和模型2(分别为P = 0.俯2和P = 0.007)之间检测到显著的负相关。随访结束时,eGFR与let-7b水平(P = 0.01)、模型1(P = 0.002)和模型2(P = 0.004)相关。与进展缓慢的患者相比,肾损伤快速进展的患者let-7b水平(P = 0.01)、模型1(P = 0.003)和模型2(P = 0.005)显著升高,达到终末期肾病(ESKD)的患者也是如此(分别为P = 0.002、P = 0.001和P = 0.001)。在接受皮质类固醇治疗的患者中结果最为显著。最后,模型1和模型2的临界值水平也可预测长期随访后的肾功能结局。
let-7b和miR-148b的血清水平及其组合,可作为长期肾功能结局的预测指标,尤其是在接受皮质类固醇治疗的患者中。